CEO
Endpoint Clinical , New Jersey
Nagaraja Srivatsan “Sri” CEO, Endpoint Clinical
Srivatsan has over thirty years of experience in growing businesses in the Digital, Data, AI, Analytics, IT, Product and Operations management areas across several industry verticals.
Currently, Srivatsan serves as the CEO of Endpoint Clinical, a global leader in Randomization and Trial Supply Management (RTSM). Previously as Chief Digital Officer for R&DS Technologies, IQVIA he was responsible for driving growth and leading product development and operations of R&DS Technologies. Prior to that, as Chief Growth Officer for EXL he oversaw the Sales & Marketing, Consulting and Strategy functions helping EXL become a Strategic digital transformation partner to its customers. Before that, as Venture partner, he grew Cognizant’s foray into Digital & Platforms. He identified, incubated and grew innovative digitally enabled ventures across the Healthcare & Life Sciences value chain.
Srivatsan was recognized as the top 100 most inspiring people in the life sciences industry award by PharmaVOICE publication and has been regularly quoted in national and global magazines on digital, Automation, Analytics, AI, healthcare & life sciences related topics.
Srivatsan holds a Bachelors in Electrical Engineering from B.I.T.S. in India and a Masters degree in Electrical Engineering & Computer Science from Northwestern University.
Disclosure information not submitted.
Upskill your AI Game for Job Search & Professional Growth
Monday, November 10, 2025
12:00 PM - 1:00 PM CT